New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Retinitis Pigmentosa
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 25 years and 125 years
- Gender
- Both males and females
Description
Safety data will be monitored to ensure continued acceptability of risks to study subjects. The utility (i.e. visual function and functional vision) and reliability of Argus II System will also be evaluated. There is no study hypothesis.
Safety data will be monitored to ensure continued acceptability of risks to study subjects. The utility (i.e. visual function and functional vision) and reliability of Argus II System will also be evaluated. There is no study hypothesis.
Tracking Information
- NCT #
- NCT01860092
- Collaborators
- Not Provided
- Investigators
- Study Director: Jessy Dorn, PhD Second Sight Medical Products, Inc.
Get Well Soon